Showing 1-1 of 1 result for "

52214-84-3

"
Amelie Lupp et al.
Arzneimittel-Forschung, 58(5), 225-241 (2008-07-01)
Fibrates are widely prescribed in hyperlpidemic patients to prevent atherosclerosis. Their therapeutic use, however, can be associated with adverse effects like gastrointestinal disorders, myalgia, myositis and hepatotoxicity. In rodents large doses can even cause hepatocellular carcinoma. Additionally, interactions with the...